Aptevo Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-36.9M | $-39.4M | $2.5M | $3.8M |
| FY2017 | $-41.6M | $-43.0M | $1.4M | $4.9M |
| FY2018 | $-51.4M | $-52.4M | $976.0K | $2.1M |
| FY2019 | $-42.4M | $-42.5M | $153.0K | $1.6M |
| FY2020 | $-29.3M | $-29.4M | $88.0K | $1.3M |
| FY2021 | $-21.7M | $-22.4M | $713.0K | $1.6M |
| FY2022 | $-21.0M | $-21.1M | $29.0K | $1.8M |
| FY2023 | $-11.7M | $-11.7M | — | $2.2M |
| FY2024 | $-23.8M | $-23.8M | — | $1.1M |
| FY2025 | $-25.6M | $-25.6M | — | $96.0K |